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https://doi.org/10.1016/j.stemcr.2018.02.005SUMMARYGenerating an unlimited source of human insulin-producing cells is a prerequisite to advance b cell replacement therapy for diabetes.
Here, we describe a 3D culture system that supports the expansion of adult human pancreatic tissue and the generation of a cell subpop-
ulation with progenitor characteristics. These cells display high aldehyde dehydrogenase activity (ALDHhi), express pancreatic progen-
itors markers (PDX1, PTF1A, CPA1, and MYC), and can form new organoids in contrast to ALDHlo cells. Interestingly, gene expression
profiling revealed that ALDHhi cells are closer to human fetal pancreatic tissue compared with adult pancreatic tissue. Endocrine lineage
markers were detected upon in vitro differentiation. Engrafted organoids differentiated toward insulin-positive (INS+) cells, and circu-
lating human C-peptide was detected upon glucose challenge 1 month after transplantation. Engrafted ALDHhi cells formed INS+ cells.
We conclude that adult humanpancreatic tissue has potential for expansion into 3D structures harboring progenitor cells with endocrine
differentiation potential.INTRODUCTION
b Cell replacement therapy is an attractive therapy to
achieve normoglycemia in patients with diabetes mellitus
due to severe b cell failure (Nijhoff et al., 2016; Ricordi
et al., 1989). The shortage of organ donors severely limits
the number of patients that are eligible for current b cell
replacement therapy, i.e., pancreas or islet transplantation.
Mature human b cells cannot be expanded in vitro without
complex dedifferentiation and redifferentiation processes
(Russ et al., 2008; Gershengorn et al., 2004). Thus, there
is an unmet clinical need to generate insulin-producing
cells from alternative cell sources to make this therapy
more widely available.
Several types of cells have been studied as possible sour-
ces of insulin-producing cells, including human embry-
onic stem cells (hESCs) and human induced pluripotent
stem cells (iPSCs). While the phenotype of these cells has
long been characterized by immature maturation (Hrvatin
et al., 2014), recently more glucose-responsive cells
have been generated from human pluripotent stem cells
in vitro (Pagliuca et al., 2014; Rezania et al., 2014), but safety
remains a major concern for any regenerative strategy us-712 Stem Cell Reports j Vol. 10 j 712–724 j March 13, 2018 j ª 2018 The Au
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An attractive alternative could be the use of putative pro-
genitor cells from adult human pancreas that give rise
to the endocrine lineage. Histological studies of human
pancreas indicate that neogenesis of insulin-producing
cells is associated with the ductal tree in obesity and preg-
nancy (Butler et al., 2003, 2010). Other studies have also
shown that some insulin-producing cells can be generated
from cultured human pancreatic ductal tissue (Bonner-
Weir et al., 2000; Yatoh et al., 2007; Lee et al., 2010; Klein
et al., 2015). We recently showed that in silico analysis of
single-cell transcriptome profiles of human adult pancre-
atic cells using a StemID algorithm predicts a distinct sub-
population of ductal cells with multipotential differentia-
tion potential (Grun et al., 2016). In mice, the existence
of postnatal endocrine progenitors within the pancreatic
ductal population has become controversial, with line-
age-tracing experiments showing contradictory results.
Although several studies were able to detect endocrine cells
derived from the ductal lineage postnatally or after injury
(Inada et al., 2008; Xu et al., 2008; Criscimanna et al.,
2011; Al-Hasani et al., 2013), others did not find this (Solar
et al., 2009; Kopp et al., 2011; Furuyama et al., 2011).thors.
ecommons.org/licenses/by-nc-nd/4.0/).
At present, expansion of human pancreatic cells in a
standard, 2D culture system is hampered by the transition
of both islet (Russ et al., 2009; Gershengorn et al., 2004)
and duct cells (Gao et al., 2003; Seeberger et al., 2006; To-
dorov et al., 2006) to a mesenchymal cell-like phenotype
during passaging. This approach does not provide the nat-
ural 3D environment of tissues, and thus important infor-
mation of cell orientation and polarity for proliferation,
growth, and differentiation are lost. In fact, proper align-
ment and polarization of progenitor cells is known to be
required for successful differentiation of fetal pancreatic
progenitor cells (Kesavan et al., 2009; Cortijo et al., 2012),
and 3D culture of fetal murine pancreatic progenitors can
be used to unravel andmimic niches important in pancreas
development (Greggio et al., 2013). Thus, it is tempting to
hypothesize that 3D culture of adult human pancreatic tis-
sue may provide a microenvironment that enhances
expansion and differentiation of pancreatic progenitors.
AMatrigel-based 3D culture systemwas developed in our
institute that yields organoids from stem cells in different
organs, with the capacity for long-term expansion and
generation of functional differentiated organ-specific cells
(Sato et al., 2011; Huch et al., 2013a, 2013b). Single isolated
adult mouse pancreatic progenitor cells can be expanded
by forming colonies or organoids in a Matrigel-based
system (Greggio et al., 2013; Huch et al., 2013a; Jin et al.,
2013). We observed that these progenitor cells are derived
from the ductal tree, express the stem cell marker leucine-
rich repeat containing G protein-coupled receptor 5
(Lgr5) in culture and are able to differentiate toward the
endocrine lineage (Huch et al., 2013a).RESULTS
Human Pancreatic Tissue Expands as Budding
Organoids
Islet-depleted pancreatic tissue after collagenase digestion
was obtained from 35 non-diabetic organ donors (age
53.6 ± 12.1 years and BMI 24.7 ± 4.0 kg/m2) and one organ
donor with a history of type 1 diabetes (age 48 years, BMI
21 kg/m2). After mechanical dissociation the small clumps
of tissue were embedded in Matrigel and supplied with an
epidermal growth factor/Noggin/R-spondin-based expan-
sion medium. More than 90% of small pancreatic cell clus-
ters formed budding structures within 3 days (Movie S1),
and expanded with a cauliflower-like appearance by day 7
(Figure 1A). Some larger cyst-like structures were present
in the organoids (Figure 1A). Organoids could be passaged
without macroscopic changes in phenotype (Figure 1B),
and maintained in culture for at least 10 passages (Fig-
ure 1C). The calculated rate for cell doubling was 67 hr
during passage 0 (P0) (n = 3). Growth rate slightly dimin-ished upon passaging (Figure 1C). The proportion of small
budding structures and cyst-like structures varied among
donors (Figure S1A). Organoids could also be generated
from pancreatic tissue from an organ donor with a history
of type 1 diabetes (Figure S1B).
Next, we analyzed the cellular composition of organoids
in the expansion phase. At day 7 (P0), 92.3% ± 5.4% of or-
ganoid cells were positive for the epithelial marker keratin
19 (KRT19), indicating a ductal phenotype (Figures 1D and
1E). Also at passage 3 (P3), the vast majority of the cells still
had a ductal phenotype (87.2% ± 8.4% of organoid cells
were KRT19+). No insulin-positive (INS+), glucagon-posi-
tive (GCG+), or amylase-positive (AMY+) cells were detected
in the organoids at day 7 of the expansion phase (P0) (Fig-
ures 1D and 1E). The organoids were organized as KRT19+
cells lining cystic or smaller elongated luminal spaces (Fig-
ure 1E). In both early and late passages, cells appeared
polarized with positive mucin-1 (MUC1) staining at the
luminal side of the KRT19+ epithelial lining (Figure 1E).
Although human pancreatic cells in 2D culture systems ac-
quire a mesenchymal cell-like phenotype (Gershengorn
et al., 2004; Gao et al., 2003; Seeberger et al., 2006; Todorov
et al., 2006; Ouziel-Yahalom et al., 2006), few vimentin-
positive cells (<2%) were observed in our organoid cultures
at P0 or P3 (Figure 1E). Thus, small adult human pancreatic
cell clusters can be expanded and passaged in 3D culture,
generating polarized ductal budding structures.
Human Pancreatic Organoids Display Pancreatic
Progenitors Clustered toward the Tips of the Budding
Structures
Since extensive growth by budding was observed, we deter-
mined the proliferative capacity of the budding structures.
Quantification showed that 27.3% ± 8.7% of the cells
within an organoid were Ki67+ at day 7 of expansion
(Figure 2A). Only a few Ki67+ cells were negative for the
duct marker KRT19 (1.3% ± 0.8% of Ki67+ cells). Ki67+ cells
were mainly observed in tips of buds and were not
frequently observed in trunk regions (Figure 2B). Also,
budding structures with wide tips and narrow trunks were
present in the organoids (Figures 2B and 2C). Labeling
with the nucleoside analog 5-ethynyl-20-deoxyuridine
that incorporates into newly synthesized DNA further
confirmed the location of the proliferative cells toward
the tip region (data not shown).
Based on the configuration of the budding structures,
we hypothesized that the tips of the budding structures
would be enriched for pancreatic progenitor cells, as
has been reported for mouse fetal pancreatic develop-
ment (Zhou et al., 2008; Shih et al., 2013). Immunostain-
ing of the organoids for the pancreatic progenitor
markers pancreatic and duodenal homeobox 1 (PDX1)
and SRY (sex-determining region Y) box 9 (SOX9)Stem Cell Reports j Vol. 10 j 712–724 j March 13, 2018 713
Figure 1. Characterization of Human
Pancreatic Organoids during Expansion
in a 3D Culture System
(A) Bright-field image of pancreatic orga-
noids (P0), expanded for 7 days in a
3D Matrigel-based culture system, reveals
extensive growth with multiple budding
structures. Some larger buds have a cyst-like
appearance. The insert shows a close-up im-
age of the cell lining (between arrowheads)
in a budding structure. Scale bar, 100 mm.
(B)Passagedorganoids (P1 andP3 are shown)
expanded in similar conditions as P0 (A), also
forming budding structures in a cauliflower-
like configuration. Scale bar, 100 mm.
(C) Growth curve of pancreatic organoids
cultured for 140 days. Cell numbers
were counted on days 0, 4, and 7 (P0), and
at the end of subsequent passages. Cells in
five wells per time point were counted
(mean ± SEM). The expansion curve is
representative of n = 3 donors.
(D) Quantification of number of cells positive
for INS, GCG, AMY, or KRT19 by immuno-
histochemistry in organoids on day 7 of
expansion culture (n = 8 donors; at least 10
organoids/donor were counted; mean ±
SEM). DAPI was used as nuclear counterstain.
(E) Non-passaged organoids (P0, upper
panels) have similar features compared with
passaged organoids (P3, lower panels). Left
panels: the majority of the cells are KRT19+
(green), with no INS+ cells (red) detected
during the expansion phase. Middle panels:
MUC1 (green) staining at the apical cell
border indicates polarization of the duct
cells. Small lumena are visible within the
organoids (arrowheads). Right panels: few
vimentin-positive (VIM+) cells (green) are
present in the organoids (arrowheads). n = 5
donors; >15 organoids/donor were stained.
DAPI was used as nuclear counterstain.
Scale bars, 50 mm. See also Figure S1.(Figure 2B) showed high PDX1 expression in the budding
structures of the organoids, particularly in tip regions,
while SOX9 was more homogeneously distributed (Fig-
ure 2B). SOX9 and PDX1 gene expression increased dur-
ing expansion (Figure S2A). Furthermore, gene expression
of LGR5 increased during this time (Figure S2B), and a
subset of cells in budding structures clearly expressed
LGR5mRNA, as assessed by smFISH (Figure S2C). No neu-
rogenin-3-positive (NEUROG3+) cells were observed in
organoids in the expansion phase (Figure 2A). Next, we
exposed the organoids to a fluorescent reagent (Aldefluor)
that identifies progenitor cells based on their increased714 Stem Cell Reports j Vol. 10 j 712–724 j March 13, 2018aldehyde dehydrogenase activity (ALDH) activity. Pancre-
atic progenitors with high expression of ALDH1 iso-
forms have recently been identified in both developing
and adult mouse pancreas (Ioannou et al., 2013; Rovira
et al., 2010). Cells concentrated in the tips of the budding
structures showed high ALDH activity (Figure 2C). The
Aldefluor reagent is optimized to detect enzyme activity
of ALDH1 isoforms, and we found that ALDH1A1 immu-
nostaining co-localized with both KRT19+ and KRT19
cells in the tips of the organoid buds, indicating the
presence of heterogeneous populations of ALDH1A1+
cells (data not shown). High ALDH activity arose during
(legend on next page)
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organoid culture as no ALDHhi cells were found in the d0
islet-depleted tissue (n = 3; data not shown). LGR5 gene
expression was higher in sorted ALDHhi compared with
ALDHlo cells (Figure S2D).
Single ALDHhi Cells Show Progenitor Characteristics
To determine whether ALDHhi cells have characteristics of
progenitor cells, organoids were dispersed into single cells,
labeled with Aldefluor, and sorted by fluorescence-acti-
vated cell sorting (FACS) (ALDHlo cells 34.0% ± 7.4%
and ALDHhi cells 25.4% ± 6.0%, n = 5) (Figure 2D). A sub-
population of ALDHhi cells derived from organoids was
able to generate small cyst-like colonies in 3D culture
(2.2% ± 0.8% of ALDHhi cells), in marked contrast to
ALDHlo cells that formed no colonies (Figures 2E, 2F,
and S3A). When organoids derived from single-sorted
ALDHhi cells were immunostained for ALDH1A1, both
ALDH1A1+ and ALDH1A1 cells were observed, indi-
cating the generation of a heterogeneous cell population
from a single ALDHhi cell (Figure S3B). When these
labeled organoids were sorted once more, yet again only
ALDHhi cells showed colony-forming potential in 3D cul-
ture (data not shown). Interestingly, complex budding
structures were not observed when single ALDHhi cells
were expanded, which could indicate the requirement of
supporting cells for self-assembly into a ductal-tree-like
configuration (Figure S3A).
Next, we characterized the ALDHhi cell population for
the presence of markers previously described for multipo-
tent progenitor cells in mouse pancreatic organogenesisFigure 2. Tips of Budding Structures of Pancreatic Organoids Con
(A) Quantification of cells positive for pancreatic progenitor and p
Organoids derived from four to six donors were analyzed (at least ten
(B) Confocal image of pancreatic organoids on day 7 of expansion. To
and ductal marker KRT19 (red). Organoid budding structures show a
Bottom: organoids were stained for SOX9 (red) and PDX1 (green). SOX9
organoids (arrowhead). PDX1+ cells (green), which frequently co-expr
with strong staining for PDX1 often observed in cells at the outerm
depicted. DAPI was used as nuclear counterstain. Scale bars, 100 mm
(C) Organoids in expansion phase for 7 days were labeled with the Al
acterized by high ALDH activity. Most ALDHhi cells (green) were loca
(D) FACS analysis of dispersed organoid cells (after 7 days in expansion
DEAB. The FACS plot shows how ALDHhi cells (i.e., cells that express hi
activity) are selected. Representative plot from n = 10 donors.
(E) Bright-field images of sorted and expanded single ALDHlo cells (lef
bar, 100 mm.
(F) Proportion of sorted ALDHlo and ALDHhi cells with colony-forming
donors).
(G) Gene expression of CPA1, PTF1A, MYC, and PDX1 in sorted ALDHlo
graph shows the gene expression ratio in ALDHhi to ALDHlo cells for t
(H) Whole-mount immunostaining for ALDH1A1 and CPA1 of organoids
and CPA1+ cells (red) in the tip of the budding structures. Some cells
CFU, colony-forming unit. See also Figures S2 and S3.
716 Stem Cell Reports j Vol. 10 j 712–724 j March 13, 2018(Zhou et al., 2008). Gene expression levels of the markers
carboxypeptidase A1 (CPA1) and pancreas-specific tran-
scription factor, 1a (PTF1A) were significantly upregulated
in ALDHhi cells compared with the ALDHlo fraction
(Figure 2G). Immunoreactivity for CPA1 was found in
ALDH1A1+ cells in the tips of organoid budding regions,
but some ALDH1A1+ cells were CPA1 (Figure 2H). Impor-
tantly, these ALDH1A1+ cells were negative for the acinar
cell marker amylase (Figure S3C). Many ALDH1A1+ cells
in the tips of budding regions buds also co-stained for
PDX1 (Figure S3D). Genes that are known to be upregu-
lated in mouse centroacinar (CAC) cells, such as HES1,
SOX9, SCA1, MET, NES, and HEY1 (Rovira et al., 2010; Ko-
pinke and Murtaugh, 2010), were analyzed in sorted
ALDHhi and ALDHlo cells. No upregulation of these
markers was present in ALDHhi compared with ALDHlo
cells (Figure S3E). HES1+ cells were present in expanded
organoids after 7 days, but their distribution was not
well defined (Figure S3F). Thus, a subpopulation of
ALDHhi cells within human pancreatic organoids has col-
ony formation capacity and expresses pancreatic progeni-
tor markers.
Transcriptional Profiling Shows Clustering of ALDHhi
Cells from Adult and Fetal Pancreatic Organoids
Since the self-assembly of adult human pancreatic tissue
into organoids in our 3D culture system resembles budding
structures previously described in pancreatic development,
we compared characteristics of organoids derived from
adult pancreatic tissue (adult pancreatic organoids) withtain Cells with Progenitor Cell Characteristics
roliferation markers in organoids on day 7 of expansion culture.
organoids/donor). Data are expressed as mean ± SEM.
p: organoids were stained for the proliferation marker Ki67 (green)
narrow trunk region (arrowhead) and a wider tip region (arrow).
+ cells were present both in the buds and in the trunk region of the
essed SOX9 (yellow), were mainly located in the budding structures
ost tip regions (arrow). Both overlay and individual channels are
.
defluor fluorescent reagent system, marking progenitor cells char-
ted in the tips of organoid buds. Scale bar, 50 mm.
culture) labeled with Aldefluor with and without the ALDH inhibitor
gh ALDH activity) and ALDHlo cells (i.e., cells that express low ALDH
t panel) and ALDHhi cells (right panel) in Matrigel for 14 days. Scale
(organoid-forming) potential. Data represent mean ± SEM (n = 3
and ALDHhi cells derived from organoids expanded for 7 days. The
he different markers. Mean ± SEM (n = 3 donors) *p < 0.05.
expanded for 7 days. Confocal images show ALDH1A1+ cells (green)
co-express the two markers. Scale bar, 50 mm.
Figure 3. Transcriptional Profiling Shows Clustering of ALDHhi Cells from Adult and Fetal Pancreatic Organoids
(A) Aldefluor labeling of adult and fetal human pancreatic organoids expanded for 7 days. Maximum projection (confocal imaging). Scale
bar, 100 mm.
(B) Principal-component analysis for gene expression profiles of the following samples: A1–A3: ALDHhi cells sorted from organoids after
7 days expansion derived from human adult pancreatic tissue (age 50.0 ± 18.7 years, BMI 22.0 ± 4.0 kg/m2). F1–F3: ALDHhi cells sorted
from organoids after 7 days expansion derived from human fetal pancreatic tissue (gestational age: F1 9 weeks, F2 20 weeks, and F3
22 weeks). P1–P4: primary fetal pancreatic tissue (gestational age: P1 9 weeks, P2 18 weeks, P3 14 weeks, and P4 10 weeks). I1–I4: adult
human islets (age 34.5 ± 17.3 years, BMI 23.8 ± 4.5 kg/m2). E1–E4: adult exocrine (islet-depleted) pancreatic tissue (age 63.5 ±
5.7 years, BMI 25.5 ± 3.7 kg/m2).
(C) Correlation cluster analysis for the gene expression profiles of the samples described in (B).human fetal pancreatic tissue and organoids derived from
this fetal pancreatic tissue (fetal pancreatic organoids).
We observed that fetal pancreatic organoids displayed a
similar morphology to adult pancreatic organoids under
the same culture conditions (Figure 3A). ALDHhi cells
were predominantly located in budding structures (Fig-ure 3A). This observation strengthened our hypothesis
that ALDHhi cells that are concentrated in tip regions
have pancreatic progenitor characteristics. We set out to
determine the level of similarity of these putative ALDHhi
progenitors isolated from adult pancreatic organoids
with ALDHhi cells derived from fetal pancreatic organoids.Stem Cell Reports j Vol. 10 j 712–724 j March 13, 2018 717
Figure 4. Endocrine Cell Markers in
Pancreatic Organoids after 7 Days of
In Vitro Differentiation
(A) Bright-field image of human pancreatic
organoids initially expanded for 7 days fol-
lowed by differentiation culture for 7 days.
DAPI was used as nuclear counterstain. Scale
bar, 100 mm.
(B) Confocal image of pancreatic organoids
immunostained for Ki67 (green) and KRT19
(red). The majority of cells were KRT19+. No
cells were Ki67+. DAPI was used as nuclear
counterstain. Scale bar, 50 mm.
(C) Confocal image of pancreatic organoids
immunostained for KRT19 (green) and INS
(red). Few INS+ (0.52%) cells were present.
DAPI was used as nuclear counterstain. Scale
bar, 50 mm.
(D) Confocal image of pancreatic progenitor
markers PDX1 (green) and SOX9 (red). DAPI
was used as nuclear counterstain. Scale bar,
50 mm.
(E) Confocal image of pancreatic progenitor
marker NEUROG3 (red). DAPI was used as
nuclear counterstain. Scale bar, 50 mm.
(F) Confocal image of pancreatic progenitor
marker NKX6.1 (green). DAPI was used as
nuclear counterstain. Scale bar, 50 mm.
(G) Gene expression of several markers in
organoids on day 7 of differentiation
compared with organoids on day 7 of
expansion. Gene expression in expansion
organoids were set to 1 (dotted line). Mean±
SEM, n = 8 donors. *p < 0.05 and **p < 0.01.
(H) Percentage of cells immunostained for
different markers on day 7 of expansion
(white bars) compared with day 7 of differ-
entiation (black bars) using confocal images.
More than 10 organoids per donor were as-
sessed. Mean± SEM, n = 4–6 donors. *p < 0.05
and **p < 0.01.
See also Figure S4.Global gene expression analysis revealed that ALDHhi cells
from adult pancreatic organoids are transcriptionally closer
to ALDHhi cells isolated from fetal pancreatic organoids
than to the adult exocrine tissue they originated from (Fig-
ures 3B and 3C). In contrast, ALDHhi cells from fetal
pancreatic organoids retained their more primitive iden-
tity, clustering closely to fetal pancreatic tissue (Figure 3B).
Furthermore, expression levels of the multipotent progen-
itor markers CPA1, PTF1A, PDX1, andMYC in ALDHhi cells
from adult pancreatic organoids were comparable with
those in ALDHhi cells from organoids derived from fetal
pancreas (no significant difference, p < 0.05; data not
shown).718 Stem Cell Reports j Vol. 10 j 712–724 j March 13, 2018Pancreatic Organoids Can Differentiate toward an
Endocrine Fate In Vitro
Since pancreatic organoids expanded from adult human
exocrine tissue express progenitor markers during expan-
sion, their differentiation potential was studied using cul-
ture conditions reported to differentiate human duct cells
(Yatoh et al., 2007; Gao et al., 2005). When P0 organoids
were transferred to low attachment plates containing dif-
ferentiation medium, their budding structure appeared
to collapse and a rounded shape was seen after 7 days
(Figure 4A). By then, growth had almost completely
stopped as indicated by the near absence of Ki67+ cells
(0.9% ± 0.4% of total cells; Figures 4B and 4H) and reduced
Cyclin D1 (CCND1) gene expression (Figure 4G). Further-
more, the proportion of ALDH1A1+ cells decreased consid-
erably from 27.0% ± 14.5% (P0 expansion day 7) to 1.4% ±
1.3% of total cells (differentiation day 7) (Figure 4H).
A marked increase in insulin gene expression after 7 days
of differentiation was observed when compared with the
end of the expansion phase (Figure 4G). Despite the consid-
erable increase in insulin gene expression with differentia-
tion, few INS+ cells were observed by immunostaining
(0.52% ± 0.22%; Figures 4C and 4H). GCG gene expression
was only slightly increased between expansion and differ-
entiation (Figure 4G), and no GCG+ cells were present in
the differentiation phase (Figure 4H). To exclude the possi-
bility that insulin was taken up from the medium, we
confirmed that INS+ cells were also positive for human
C-peptide (Figure S4A). No AMY+ cells were observed and
the majority of cells remained KRT19+ during differentia-
tion (83.4% ± 14.5% of cells; Figure 4H), even though
gene expression of KRT19 decreased (Figure 4G).
Gene expression of the endocrine progenitor marker
NEUROG3 and b cell marker NKX 6 homeobox 1
(NKX6.1) were significantly upregulated during the differ-
entiation phase (Figure 4G). NEUROG3+ cells could also
be identified by immunostaining in the ‘‘collapsed’’ orga-
noids (Figures 4E and 4H). In addition,more cells expressed
NKX6.1 in the differentiation phase compared with the
expansion phase (Figures 4F and 4H). Conversely, no
change was found in gene expression of the pancreatic pro-
genitor markers PDX1 and SOX9 upon differentiation (Fig-
ure 4G) or the number of PDX1+ and SOX9+ cells (Figures
4D and 4H). Thus, upon in vitro differentiation, pancreatic
progenitors can be directed along the endocrine lineage.
Human Pancreatic Tissue Can Be Cryopreserved
without Losing Expansion or Differentiation
Capacities
With therapeutic purposes in mind, we explored the possi-
bility of cryopreserving pancreatic tissue before organoid
expansion. Freshly retrieved tissue (day 0) was compared
with cryopreserved tissue (day 0) from the same donors
(n = 4). Growth of organoids with budding structures was
observed from both groups (Figure S4B), but the organoids
grown from cryopreserved starting material had more
cystic appearance than organoids grown from freshly iso-
lated material. When subjected to in vitro differentiation,
no significant differences in gene expression were found
(Figure S4C). Thus, organoids can be grown from cryopre-
served primary human adult pancreatic tissue.
Human Pancreatic Organoids Generate Insulin-
Producing Cells In Vivo
While the in vitro differentiation experiments indicated dif-
ferentiation toward an endocrine lineage based on geneexpression analysis, only a few INS+ cells were observed.
It is well known that human ESC differentiate into insu-
lin-producing cells after implantation into mice (Kroon
et al., 2008). Therefore, we tested the capacity of pancreatic
organoids to further differentiate in vivo after transplanta-
tion under the kidney capsule of immunodeficient mice.
One day after transplantation the majority of grafted cells
were KRT19+ and no INS+ cells were observed (Figure 5A).
However, pancreatic organoids from the same donor
1 month after transplantation showed INS+ cells within
the ductal lining (Figure 5B). Organoids derived from
each donor (n = 8) were able to generate 1.5% ± 0.2%
INS+ cells within the ductal lining (n = 8; Figure 5B). No
difference in the proportion of INS+ cells was observed in
the hyperglycemic animals (Figure 5C). Production of insu-
lin was confirmed by immunostaining of C-peptide in
INS+ cells (CPEP) (Figure S5A). Furthermore, insulin was
co-expressed with several functional endocrine markers
(PDX1, IAPP, NKX6.1, and SYP) but not with GCG (Figures
S5B–S5E). The differentiation phase in vitro was necessary
for the appearance of INS+ cells as transplantation of orga-
noids 1 week after expansion yielded either no grafts or
only large cystic structures with no hormone-positive cells
(data not shown).
Human C-peptide could be readily measured in normo-
glycemic and hyperglycemic mice after a glucose challenge
indicating that human insulin was released into the circu-
lation upon a common b cell stimulus (Figure 5D). Basal
human C-peptide was also present in normoglycemic
mice before the glucose challenge (89.2 ± 59.9 pmol/L,
n = 8). Blood glucose of graftedmice did not decrease signif-
icantly in either hyperglycemic mice (26.5 ± 3.9 mmol/L at
day 0 versus 24.3 ± 3.8 mmol/L at day 30, n = 8) or in the
normoglycemic group (8.6 ± 1.3 mmol/L at day 0 versus
6.7 ± 2.4 mmol/L at day 30, n = 8). Thus, graft function
was detectable but not sufficient to restore normoglycemia
within 1 month after organoid transplantation in hyper-
glycemic mice.
Sorted ALDHhi cells derived from organoids expanded
for 7 days were also differentiated for 1 week in vitro and
subsequently transplanted under the kidney capsule of
normoglycemic immunodeficient mice. After 50 days,
retrieved grafts contained both KRT19+ and C-peptide+
cells (Figure 5E).DISCUSSION
Our data indicate that adult human pancreatic tissue can
be expanded as 3D organoids and long-term expansion
can be achieved by passaging these pancreatic organoids.
Cryopreservation of the pancreatic tissue is possible
without losing these characteristics. A subpopulation ofStem Cell Reports j Vol. 10 j 712–724 j March 13, 2018 719
Figure 5. Human Pancreatic Organoids
Generate Insulin-Producing Cells In Vivo
Grafts composed of in vitro differentiated
organoids derived from islet-depleted
exocrine pancreatic tissue were transplanted
under the mouse kidney capsule after 7 days
of expansion and 7 days of differentiation.
(A) Day 1 after transplantation. Immuno-
staining for KRT19 (green) and INS (red). No
INS+ cells are present. DAPI (blue) was used
as nuclear counterstain. Scale bar, 50 mm.
(B) Day 30 after transplantation. Trans-
planted organoids formed a ductal network
(KRT19, green) and many INS+ cells (red) are
present within the ductal lining (arrows
indicate INS+ cells). DAPI (blue) was used as
nuclear counterstain. Scale bar, 50 mm.
(C) Percentage of INS+ cells in the ductal
lining 1 month after transplantation. For
each donor, grafts were transplanted in both
normoglycemic and hyperglycemic mice,
and two mice were transplanted per donor.
No significant difference in the number of
INS+ cells between the two groups of mice
was found. Mean ± SEM, n = 8 donors.
(D) Human C-peptide concentration after
a glucose challenge in mice 1 month
after organoid transplantation. Grafts were
transplanted in either normoglycemic mice
or hyperglycemic mice, and two mice were
transplanted per donor. No significant dif-
ference in human C-peptide concentration
between the two groups of mice was
observed. Mean ± SEM, n = 8 donors.
(E) Confocal image of a graft of sorted ALDHhi
cells isolated from organoids after expansion
for 7 days. TheALDHhi cellswere differentiated
for 7 days in vitro before transplantation under
the kidney capsule of normoglycemic mice
(n = 3 donors, 1 mouse per donor). The graft
was retrievedafter 50daysand containedboth
KRT19+ and CPEP+ cells. Cells co-expressing
KRT19 and C-peptide indicate a transition
stage from a duct (-like) phenotype to a b
(-like) cell phenotype.DAPI (blue)wasusedas
nuclear counterstain. Scale bar, 50 mm.
See also Figure S5.cells from the organoids have progenitor characteristics
and give rise to endocrine cells after transplantation.
Progress to expand human adult pancreatic tissue and
thus exploration of its capacity for endocrine cell differen-
tiation has been hampered by epithelial-to-mesenchymal
transition in 2D culture systems. The 3D culture system
we have developed here provides an environment that al-
lows substantial growth of human pancreatic cells starting
from minced tissue. Recently we showed that adult mouse720 Stem Cell Reports j Vol. 10 j 712–724 j March 13, 2018pancreatic organoids can also be expanded using similar
culture conditions (Huch et al., 2013a). We and others
described Matrigel-based culture methods for expansion
of dispersed exocrine cells from adult mouse (Huch et al.,
2013a; Jin et al., 2013) and human (Boj et al., 2015)
pancreas and for expansion of genetically modified human
pancreatic ductal cells (Lee et al., 2013). The striking aspect
of our expansion protocol is the self-organization of the tis-
sue into organoids with complex budding structures. These
organoids display a remarkable KRT19+ epithelial tree-like
structure with apical-basal polarity. This configuration
has been shown for mouse embryonic pancreas tissue
in vivo and in vitro (Greggio et al., 2013; Zhou et al.,
2008), and is present during human pancreatic organogen-
esis (Jennings et al., 2013). Similar culture systems enabled
the expansion of human intestine and stomach in complex
cell configurations, also called organoids, that appear to
recapitulate organogenesis and tissue regeneration (Sato
et al., 2011; Barker et al., 2010).
During embryogenesis, the tip regions of the expanding
ductal trees in the developing pancreas harbor progenitor
cells (Zhou et al., 2008; Jennings et al., 2013; Solar et al.,
2009); and, in adult human tissue, we predicted, from sin-
gle-cell transcriptome data, that the progenitor population
in human adult pancreatic cells resides among the ductal
population (Grun et al., 2016). The morphology of the
pancreatic organoids (derived from adult pancreatic tissue)
in our study allowed us to search for putative progenitors
in the budding structures. ALDHhi cells had differentially
high expression of the progenitor markers PDX1, CPA1,
MYC, and PTF1A (Zhou et al., 2008). In addition, we estab-
lished organoid culture fromhuman fetal pancreatic tissue.
These fetal pancreatic organoids also contained ALDHhi
cells in budding structures. Interestingly, transcriptional
profiling revealed that ALDHhi cells from adult pancreatic
organoids were closer to ALDHhi cells from fetal pancreatic
organoids than to adult exocrine tissue (i.e., the islet-
depleted tissue before expansion). This indicates a reprog-
ramming of a subset of adult pancreatic cells to a progeni-
tor-like stage.
Organoids expanded from human pancreas and trans-
planted in immunodeficient mice gave rise to insulin-
producing cells after 1 month. The location of the
insulin-producing cells in the grafts, i.e., in close prox-
imity of or within the ductal lining, and the increased
number of insulin-positive cells after engraftment
compared with the initial cell population, support the
concept that these cells were newly generated. However,
while human C-peptide could be detected in the circula-
tion the number of b cells was not sufficient to restore
normoglycemia in diabetic mice 1 month after transplan-
tation. In a recent study by Lee et al. (2013), the authors
also showed that a subpopulation of expanded ductal
cells could differentiate to insulin-secreting cells using
an alternative approach of adenovirus-mediated expres-
sion of pro-endocrine factors and co-transplantation
with mouse embryonic fibroblasts. In summary, although
culture conditions need to be optimized to increase graft
efficacy, our study provides a proof-of-concept that this
3D culture system can be used to expand primary human
ductal cells that can differentiate to an endocrine fate
without the need for genetic modification.The origin of the ALDHhi cells in our system is unclear.
An ALDHhi progenitor cell population has been identified
in a subset of adult ductal/CAC cells (Rovira et al., 2010)
and in the developing pancreas (Ioannou et al., 2013) of
mice, and these cells had the ability to self-renew and to
differentiate into both endocrine and exocrine cells.
Notably, several studies have recently attributed a func-
tional role to ALDH1 isoforms during pancreas develop-
ment in humans (Li et al., 2014), mice (Ostrom et al.,
2008), and zebrafish (Matsuda et al., 2013). Our data indi-
cate that the specific culture conditions we developed sup-
port this progenitor state.Whether these ALDHhi cells have
a CAC origin or not warrants further investigation. At pre-
sent this question is challenging as there is a lack ofmarkers
specific for human adult CACs. Inmaturemurine pancreas,
HES1 expressionmarks terminal ductal or CACs, whereas it
identifies MPCs in early embryonic pancreas (until e11.5),
and exocrine-restricted progenitors from e13.5 until birth
(Kopinke and Murtaugh, 2010). Here, we found that
HES1was slightly upregulated at themRNA level in ALDHhi
cells, but HES1 protein expression was not restricted to
the tips of the budding structures where the majority of
ALDHhi cells reside. Finally, the ALDHhi population is het-
erogeneous, with only a small proportion of cells able to
expand in vitro. Therefore, additional cell surface markers
will be necessary to efficiently enrich and characterize the
progenitor subpopulation from this heterogeneous popula-
tion of ALDHhi cells.
It has been unclear whether an endocrine/multipo-
tent progenitor population exists in the adult human
pancreas. Indeed, classical definitions of what constitutes
an adult stem cell population are under debate (Clevers,
2015). However, we provide a proof-of-concept for the
existence of a ALDHhi population of human pancreatic
cells (most likely KRT19+ cells) that appears under specific
culture conditions, and that has the capacity to differen-
tiate into an endocrine cell phenotype. Aldefluor has
been used to detect ALDHhi stem/progenitor cells in mul-
tiple tissues (Balber, 2011). Here, we show that this cell
population expresses the pancreatic progenitor markers
CPA1, PDX1, MYC, and PTF1A. Furthermore, the gene
expression profile of adult pancreatic ALDHhi population
presents a high degree of similarity with fetal pancreatic
ALDHhi cells.
Finally, since these cells are derived from the adult hu-
man pancreas and, thus, have already committed to a
pancreatic fate, differentiation to the b cell lineage may
be easier to achieve than differentiation of other adult
stem/progenitor cells. In current allogeneic and autologous
islet transplantation contaminating non-islet cells from
the human pancreas are always co-transplanted with
islets into human recipients without adverse effects (Ichii
et al., 2008). Therefore, expanded and differentiated adultStem Cell Reports j Vol. 10 j 712–724 j March 13, 2018 721
human pancreatic cells are likely to be relatively safe
compared with embryonic or induced pluripotent cell lines
for future b cell replacement therapy programs.EXPERIMENTAL PROCEDURES
Human Primary Tissue
Adult Pancreatic Tissue
Islet-depleted pancreatic tissue and human islets that could not be
used for clinical transplantationwere used in the studies according
to national laws and if research content was available.
Fetal Pancreatic Tissue
Fetal pancreatic tissue from elective abortions was used after writ-
ten (parental) informed consent was provided. Collection and use
of human fetal tissue for research was approved by the Medical
Ethics committee of the LUMC.
Generation of Human and Fetal Pancreatic Organoids
Human adult islet-depleted pancreatic tissue was obtained after
human islet isolation procedures. For culture of adult pancreatic
organoids, small pieces of exocrine tissue were plated and
expanded in Matrigel (BD Biosciences). Human fetal pancreatic
tissue was obtained from fetuses with a gestational age of 9,
20, and 22 weeks. For culture of fetal pancreatic organoids,
small pieces of human fetal pancreatic tissue were plated and
expanded in Matrigel similar to adult pancreatic organoids. A
progenitor population within the organoids was identified using
the Aldefluor fluorescent reagent system (STEMCELL), which is
based on detection of high ALDH activity in progenitor cells.
ALDHhi and ALDHlo cell populations were sorted and plated in
Matrigel before analysis. Human and fetal pancreatic organoids
were analyzed by immunohistochemistry, RNA sequencing,
qPCR, and smFISH, For a detailed description see Supplemental
Experimental Procedures.
In Vitro and In Vivo Differentiation of Human
Pancreatic Organoids
After expansion, adult pancreatic organoids were retrieved from
the Matrigel and analyzed, cryopreserved in liquid nitrogen, or
transferred to a differentiation culture medium (3 mL), character-
ized by absence of growth factors, in six-well hydrophobic plates
(Corning). Organoids were cultured for 7–18 days before analysis
or transplantation under the kidney capsule in normoglycemic
or hyperglycemic immunodeficient mice. Human C-peptide was
measured and grafts were analyzed up to 1 month after transplan-
tation. For a detailed description see Supplemental Experimental
Procedures.
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2018.02.005.
AUTHOR CONTRIBUTIONS
C.J.M.L. and N.W.G. performed the key experiments and co-wrote
themanuscriptwith E.J.P.d.K., H.C., and F.C. J.B. performed the ex-
periments with fetal pancreatic organoids. F.R. and L.v.G. provided
technical assistance. M.H., S.F.B., T.S., H.C., R.G.J.V., and H.H. pro-
vided expertise on organoids culture systems and culture of human
cells. S.B.-W. provided expertise on human pancreatic duct cells.
T.J.R. provided the infrastructure for humanpancreatic tissue isola-
tion. L.K. and A.v.O. gave support for the RNA sequencing experi-
ments. S.M.C.d.S.L. and M.S.R. provided human fetal pancreatic
tissue. M.A.E. provided human adult pancreatic tissue.
ACKNOWLEDGMENTS
This work was financially supported by the DON foundation, the
Dutch Diabetes Research Foundation, the Tjanka Foundation,
and the Diabetes Cell Therapy Initiative. We thank Dr. Vrolijk for
help with analyses of immunostaining (ImageJ-based data ana-
lyses), Yves Heremans (H.H. lab) andAnnemieke Tons (LeidenUni-
versity Medical Center, Leiden) for helping with the NEUROG3
staining, the Hubrecht imaging center for microscope assistance,
and Stefan van der Elst (Geijsen lab, Hubrecht Institute, Utrecht)
for help with FACS and analysis.
Received: October 24, 2017
Revised: February 8, 2018
Accepted: February 9, 2018
Published: March 13, 2018REFERENCES
Al-Hasani, K., Pfeifer, A., Courtney, M., Ben-Othman, N., Gjernes,
E., Vieira, A., Druelle, N., Avolio, F., Ravassard, P., Leuckx, G., et al.
(2013). Adult duct-lining cells can reprogram into beta-like cells
able to counter repeated cycles of toxin-induced diabetes. Dev.
Cell 26, 86–100.
Balber, A.E. (2011). Concise review: aldehyde dehydrogenase
bright stem and progenitor cell populations from normal tissues:
characteristics, activities, and emerging uses in regenerative medi-
cine. Stem Cells 29, 570–575.
Barker, N., Huch,M., Kujala, P., van deWetering,M., Snippert, H.J.,
van Es, J.H., Sato, T., Stange, D.E., Begthel, H., van den Born, M.,
et al. (2010). Lgr5(+ve) stem cells drive self-renewal in the stomach
and build long-lived gastric units in vitro. Cell Stem Cell 6, 25–36.
Boj, S.F., Hwang, C.I., Baker, L.A., Chio, I.I., Engle, D.D., Corbo, V.,
Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M.S., et al. (2015).
Organoid models of human and mouse ductal pancreatic cancer.
Cell 160, 324–338.
Bonner-Weir, S., Taneja, M., Weir, G.C., Tatarkiewicz, K., Song,
K.H., Sharma, A., and O’Neil, J.J. (2000). In vitro cultivation of hu-
man islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA
97, 7999–8004.
Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A.,
and Butler, P.C. (2003). Beta-cell deficit and increased beta-cell
apoptosis in humans with type 2 diabetes. Diabetes 52,
102–110.
Butler, A.E., Cao-Minh, L., Galasso, R., Rizza, R.A., Corradin, A.,
Cobelli, C., and Butler, P.C. (2010). Adaptive changes in pancreatic
beta cell fractional area and beta cell turnover in human preg-
nancy. Diabetologia 53, 2167–2176.
Clevers, H. (2015). STEM CELLS. What is an adult stem cell? Sci-
ence 350, 1319–1320.
Cortijo, C., Gouzi, M., Tissir, F., and Grapin-Botton, A. (2012).
Planar cell polarity controls pancreatic beta cell differentiation
and glucose homeostasis. Cell Rep. 2, 1593–1606.
Criscimanna, A., Speicher, J.A., Houshmand, G., Shiota, C.,
Prasadan, K., Ji, B., Logsdon, C.D., Gittes, G.K., and Esni, F.
(2011). Duct cells contribute to regeneration of endocrine and
acinar cells following pancreatic damage in adult mice. Gastroen-
terology 141, 1451–1462, 1462.e1-6.
Furuyama, K., Kawaguchi, Y., Akiyama, H., Horiguchi, M.,
Kodama, S., Kuhara, T., Hosokawa, S., Elbahrawy, A., Soeda, T.,
Koizumi, M., et al. (2011). Continuous cell supply from a
Sox9-expressing progenitor zone in adult liver, exocrine pancreas
and intestine. Nat. Genet. 43, 34–41.
Gao, R., Ustinov, J., Pulkkinen, M.A., Lundin, K., Korsgren, O., and
Otonkoski, T. (2003). Characterization of endocrine progenitor
cells and critical factors for their differentiation in human adult
pancreatic cell culture. Diabetes 52, 2007–2015.
Gao, R., Ustinov, J., Korsgren, O., andOtonkoski, T. (2005). In vitro
neogenesis of human islets reflects the plasticity of differentiated
human pancreatic cells. Diabetologia 48, 2296–2304.
Gershengorn, M.C., Hardikar, A.A., Wei, C., Geras-Raaka, E.,
Marcus-Samuels, B., and Raaka, B.M. (2004). Epithelial-to-mesen-
chymal transition generates proliferative human islet precursor
cells. Science 306, 2261–2264.
Greggio, C., De, F.F., Figueiredo-Larsen, M., Gobaa, S., Ranga, A.,
Semb, H., Lutolf, M., and Grapin-Botton, A. (2013). Artificial
three-dimensional niches deconstruct pancreas development
in vitro. Development 140, 4452–4462.
Grun,D.,Muraro,M.J., Boisset, J.C.,Wiebrands, K., Lyubimova, A.,
Dharmadhikari, G., van den Born,M., van, E.J., Jansen, E., Clevers,
H., et al. (2016). De novo prediction of stem cell identity using sin-
gle-cell transcriptome data. Cell Stem Cell 19, 266–277.
Hrvatin, S., O’Donnell, C.W., Deng, F., Millman, J.R., Pagliuca,
F.W., DiIorio, P., Rezania, A., Gifford, D.K., and Melton, D.A.
(2014). Differentiated human stem cells resemble fetal, not adult,
beta cells. Proc. Natl. Acad. Sci. USA 111, 3038–3043.
Huch, M., Bonfanti, P., Boj, S.F., Sato, T., Loomans, C.J., van de
Wetering, M., Sojoodi, M., Li, V.S., Schuijers, J., Gracanin, A.,
et al. (2013a). Unlimited in vitro expansion of adult bi-potent
pancreas progenitors through the Lgr5/R-spondin axis. EMBO J.
32, 2708–2721.
Huch, M., Dorrell, C., Boj, S.F., van Es, J.H., Li, V.S., van de
Wetering, M., Sato, T., Hamer, K., Sasaki, N., Finegold, M.J., et al.
(2013b). In vitro expansion of single Lgr5+ liver stem cells induced
by Wnt-driven regeneration. Nature 494, 247–250.
Ichii, H., Miki, A., Yamamoto, T., Molano, R.D., Barker, S., Mita, A.,
Rodriguez-Diaz, R., Klein, D., Pastori, R., Alejandro, R., et al. (2008).Characterization of pancreatic ductal cells in human islet prepara-
tions. Lab. Invest. 88, 1167–1177.
Inada, A., Nienaber, C., Katsuta, H., Fujitani, Y., Levine, J., Morita,
R., Sharma, A., and Bonner-Weir, S. (2008). Carbonic anhydrase
II-positive pancreatic cells are progenitors for both endocrine
and exocrine pancreas after birth. Proc. Natl. Acad. Sci. USA 105,
19915–19919.
Ioannou,M., Serafimidis, I., Arnes, L., Sussel, L., Singh, S., Vasiliou,
V., andGavalas, A. (2013). ALDH1B1 is a potential stem/progenitor
marker for multiple pancreas progenitor pools. Dev. Biol. 374,
153–163.
Jennings, R.E., Berry, A.A., Kirkwood-Wilson, R., Roberts, N.A.,
Hearn, T., Salisbury, R.J., Blaylock, J., Piper, H.K., and Hanley,
N.A. (2013). Development of the human pancreas from foregut
to endocrine commitment. Diabetes 62, 3514–3522.
Jin, L., Feng, T., Shih, H.P., Zerda, R., Luo, A., Hsu, J., Mahdavi, A.,
Sander, M., Tirrell, D.A., Riggs, A.D., et al. (2013). Colony-forming
cells in the adult mouse pancreas are expandable in Matrigel and
form endocrine/acinar colonies in laminin hydrogel. Proc. Natl.
Acad. Sci. USA 110, 3907–3912.
Kesavan, G., Sand, F.W., Greiner, T.U., Johansson, J.K., Kobberup,
S., Wu, X., Brakebusch, C., and Semb, H. (2009). Cdc42-mediated
tubulogenesis controls cell specification. Cell 139, 791–801.
Klein, D., Alvarez-Cubela, S., Lanzoni, G., Vargas, N., Prabakar, K.R.,
Boulina,M., Ricordi, C., Inverardi, L., Pastori, R.L., andDominguez-
Bendala, J. (2015). BMP-7 induces adult human pancreatic
exocrine-to-endocrine conversion. Diabetes 64, 4123–4134.
Kopinke, D., and Murtaugh, L.C. (2010). Exocrine-to-endocrine
differentiation is detectable only prior to birth in the uninjured
mouse pancreas. BMC. Dev. Biol. 10, 38.
Kopp, J.L., Dubois, C.L., Schaffer, A.E., Hao, E., Shih,H.P., Seymour,
P.A., Ma, J., and Sander, M. (2011). Sox9+ ductal cells are multipo-
tent progenitors throughout development but do not produce new
endocrine cells in the normal or injured adult pancreas. Develop-
ment 138, 653–665.
Kroon, E., Martinson, L.A., Kadoya, K., Bang, A.G., Kelly, O.G., Eli-
azer, S., Young, H., Richardson, M., Smart, N.G., Cunningham, J.,
et al. (2008). Pancreatic endodermderived fromhuman embryonic
stem cells generates glucose-responsive insulin-secreting cells
in vivo. Nat. Biotechnol. 26, 443–452.
Lee, J.H., Jo, J., Hardikar, A.A., Periwal, V., and Rane, S.G. (2010).
Cdk4 regulates recruitment of quiescent beta-cells and ductal
epithelial progenitors to reconstitute beta-cell mass. PLoS One 5,
e8653.
Lee, J., Sugiyama, T., Liu, Y., Wang, J., Gu, X., Lei, J., Markmann,
J.F., Miyazaki, S., Miyazaki, J., Szot, G.L., et al. (2013). Expansion
and conversion of human pancreatic ductal cells into insulin-
secreting endocrine cells. Elife 2, e00940.
Li, J., Feng, Z.C., Yeung, F.S., Wong, M.R., Oakie, A., Fellows, G.F.,
Goodyer, C.G., Hess, D.A., and Wang, R. (2014). Aldehyde dehy-
drogenase 1 activity in the developing human pancreas modulates
retinoic acid signalling in mediating islet differentiation and sur-
vival. Diabetologia 57, 754–764.Stem Cell Reports j Vol. 10 j 712–724 j March 13, 2018 723
Lund, R.J., Narva, E., and Lahesmaa, R. (2012). Genetic and epige-
netic stability of humanpluripotent stem cells. Nat. Rev. Genet. 13,
732–744.
Matsuda, H., Parsons, M.J., and Leach, S.D. (2013). Aldh1-express-
ing endocrine progenitor cells regulate secondary islet formation
in larval zebrafish pancreas. PLoS One 8, e74350.
Mummery, C. (2011). Induced pluripotent stem cells – a
cautionary note. N. Engl. J. Med. 364, 2160–2162.
Nijhoff, M.F., Engelse, M.A., Dubbeld, J., Braat, A.E., Ringers, J.,
Roelen, D.L., van Erkel, A.R., Spijker, H.S., Bouwsma, H., van der
Boog, P.J., et al. (2016). Glycemic stability through islet-after-
kidney transplantation using an Alemtuzumab-based induction
regimen and long-term triple-maintenance immunosuppression.
Am. J. Transplant. 16, 246–253.
Ostrom, M., Loffler, K.A., Edfalk, S., Selander, L., Dahl, U., Ricordi,
C., Jeon, J., Correa-Medina, M., Diez, J., and Edlund, H. (2008).
Retinoic acid promotes the generation of pancreatic endocrine
progenitor cells and their further differentiation into beta-cells.
PLoS One 3, e2841.
Ouziel-Yahalom, L., Zalzman, M., Anker-Kitai, L., Knoller, S., Bar,
Y., Glandt,M., Herold, K., and Efrat, S. (2006). Expansion and redif-
ferentiation of adult human pancreatic islet cells. Biochem. Bio-
phys. Res. Commun. 341, 291–298.
Pagliuca, F.W., Millman, J.R., Gurtler, M., Segel, M., Van, D.A., Ryu,
J.H., Peterson, Q.P., Greiner, D., and Melton, D.A. (2014). Genera-
tion of functional human pancreatic beta cells in vitro. Cell 159,
428–439.
Rezania, A., Bruin, J.E., Arora, P., Rubin, A., Batushansky, I., Asadi,
A., O’Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., et al.
(2014). Reversal of diabetes with insulin-producing cells derived
in vitro from human pluripotent stem cells. Nat. Biotechnol. 32,
1121–1133.
Ricordi, C., Lacy, P.E., and Scharp, D.W. (1989). Automated islet
isolation from human pancreas. Diabetes 38 (Suppl 1), 140–142.
Rovira, M., Scott, S.G., Liss, A.S., Jensen, J., Thayer, S.P., and Leach,
S.D. (2010). Isolation and characterization of centroacinar/termi-
nal ductal progenitor cells in adult mouse pancreas. Proc. Natl.
Acad. Sci. USA 107, 75–80.724 Stem Cell Reports j Vol. 10 j 712–724 j March 13, 2018Russ, H.A., Bar, Y., Ravassard, P., and Efrat, S. (2008). In vitro prolif-
eration of cells derived from adult human beta-cells revealed by
cell-lineage tracing. Diabetes 57, 1575–1583.
Russ, H.A., Ravassard, P., Kerr-Conte, J., Pattou, F., and Efrat, S.
(2009). Epithelial-mesenchymal transition in cells expanded
in vitro from lineage-traced adult human pancreatic beta cells.
PLoS One 4, e6417.
Sato, T., Stange, D.E., Ferrante, M., Vries, R.G., van Es, J.H., van
den Brink, S., Van Houdt, W.J., Pronk, A., Van, G.J., Siersema,
P.D., et al. (2011). Long-term expansion of epithelial organoids
from human colon, adenoma, adenocarcinoma, and Barrett’s
epithelium. Gastroenterology 141, 1762–1772.
Seeberger, K.L., Dufour, J.M., Shapiro, A.M., Lakey, J.R., Rajotte,
R.V., and Korbutt, G.S. (2006). Expansion of mesenchymal stem
cells from human pancreatic ductal epithelium. Lab. Invest. 86,
141–153.
Shih, H.P., Wang, A., and Sander, M. (2013). Pancreas organogen-
esis: from lineage determination to morphogenesis. Annu. Rev.
Cell Dev. Biol. 29, 81–105.
Solar, M., Cardalda, C., Houbracken, I., Martin, M., Maestro, M.A.,
De,M.N., Xu, X., Grau, V., Heimberg, H., Bouwens, L., et al. (2009).
Pancreatic exocrine duct cells give rise to insulin-producing beta
cells during embryogenesis but not after birth. Dev. Cell 17,
849–860.
Todorov, I., Omori, K., Pascual, M., Rawson, J., Nair, I., Valiente, L.,
Vuong, T., Matsuda, T., Orr, C., Ferreri, K., et al. (2006). Generation
of human islets through expansion and differentiation of non-islet
pancreatic cells discarded (pancreatic discard) after islet isolation.
Pancreas 32, 130–138.
Xu, X., D’Hoker, J., Stange, G., Bonne, S., De, L.N., Xiao, X., Van de,
C.M., Mellitzer, G., Ling, Z., Pipeleers, D., et al. (2008). Beta cells
can be generated from endogenous progenitors in injured adult
mouse pancreas. Cell 132, 197–207.
Yatoh, S., Dodge, R., Akashi, T., Omer, A., Sharma, A., Weir, G.C.,
and Bonner-Weir, S. (2007). Differentiation of affinity-purified hu-
man pancreatic duct cells to beta-cells. Diabetes 56, 1802–1809.
Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J., and Melton, D.A.
(2008). In vivo reprogramming of adult pancreatic exocrine cells
to beta-cells. Nature 455, 627–632.
